Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Abscess as a Manifestation of Autoinflammatory Disease

Katherine Chakrabarti, MD, & Andrew Vreede, MD  |  Issue: June 2022  |  June 14, 2022

Axial CT of the liver, with the hepatic lobe abscess indicated by the arrow.

Figure 1. Axial CT of the liver, with the hepatic lobe abscess indicated by the arrow.

Abscesses are typically caused by infections, but some are, instead, sterile. Aseptic abscesses (AAs) are characterized by the same neutrophil-rich histo­pathology as infectious abscesses; however, they don’t improve with antibiotics. Rather, AAs require treatment with anti-inflammatory medications. Although relatively rare, this phenomenon is important for rheumatologists to recognize given its frequent association with under­lying systemic inflammatory diseases.

We describe two cases of AA seen by an inpatient rheumatology consultation service within a single year.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Case 1

A 46-year-old man presented to the hospital with fever and abdominal pain. His history was notable for six hospitalizations during the previous four years for recurrent hepatic abscesses. During each of these episodes, he had negative aerobic and anaerobic cultures of abscess aspirates and blood. Additional negative microbiological testing included human immunodeficiency virus (HIV), Coxiella, echinococcus and Entamoeba histolytica. Universal polymerase chain reaction testing (completed through the University of Washington Medical Center laboratory) for bacteria, fungi, mycobacterium tuberculous and nontuberculous mycobacterium was negative.

Axial CT showing a chest wall abscess.

Figure 2. Axial CT showing a chest wall abscess.

His condition had temporarily improved with antibiotics during all but the last of the previous episodes. For that hospitalization, he was treated for a possible anatomic abnormality with placement of a biliary stent. He had experienced no recurrent abscess formation over the subsequent 18 months until the current hospitalization.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

During the current hospitalization, the patient’s vital signs on admission were notable for a temperature of 103.5°F and sinus tachycardia of 110 beats per minute.

The initial laboratory testing demon­strated mild leukocytosis with a total white blood cell (WBC) count of 12.9×109/L (reference range [RR]: 4.0–11.0×109/L), and elevated inflammatory markers with an erythrocyte sedimentation rate (ESR) of 82 mm/hour (RR: 0–15 mm/hour for men younger than 50) and a C-reactive protein (CRP) of 32.6 mg/dL (RR: 0–0.6 mg/dL).

Imaging revealed four, right-lobe, hepatic abscesses measuring up to 3.0 cm in diameter (see Figure 1, above left), as well as an anorectal abscess and possible fistula of the gluteal fold.

One should have a strong suspicion for aseptic abscesses in a patient with abscesses that do not appropriately respond to antibiotic therapy.

Broad-spectrum antibiotics were initiated.

Axial CT showing a second chest wall abscess.

Figure 3. Axial CT showing a second chest wall abscess.

Aerobic and anaerobic cultures of abscess aspirate failed to identify an organism. Fungal and acid-fast bacillus (AFB) cultures were negative. Additional tests, including hepatitis B and C serologies, anti-Bartonella antibody, Fungitell, blastomyces antigen and cryptococcal antigen, were all negative.

The patient’s history was also notable for recurrent, oral, aphthous ulcers and pyoderma gangrenosum in the preceding year. Due to the concern for occult inflammatory bowel disease (IBD), fecal calprotectin was obtained, but was indeterminate at 89.7 mg/kg (negative: <50 mg/kg).

Colonoscopy demonstrated a possible perianal fistula and a single rectal ulcer. Biopsy of the terminal ileum was unremark­able. Rectal ulcer biopsy demonstrated non-specific reactive changes, and a biopsy of perianal tissue demonstrated acute and chronic inflammation with ulcer and abscess. X-ray and magnetic resonance imaging (MRI) of the pelvis demonstrated sacroiliitis, despite a lack of inflammatory back pain.

Due to a lack of improvement with antimicrobials and a high suspicion for IBD, antibiotics were stopped, and he was started on 40 mg of prednisone daily. His fever and abdominal pain resolved. Adalimumab was initiated with no recurrence of abscesses to the present time.

Case 2

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:abscessaseptic abscesscase reportSAPHO

Related Articles

    Case Report: Possible Overlapping Vasculitis & Ulcerative Colitis

    January 17, 2020

    A 42-year-old man with a history of ulcerative colitis (UC), primary sclerosing cholangitis (PSC) and chronic sinusitis was referred to a rheumatologist to evaluate for a possible diagnosis of systemic vasculitis. This patient had developed new skin lesions, gingival hypertrophy and ulcerating tracheobronchitis, concerning for possible granulomatosis with polyangiitis (GPA). Since 1994, the patient had…

    Case Report: Sweet Syndrome as an Initial Presentation of Crohn’s Disease

    July 13, 2022

    Acute febrile neutrophilic dermatosis, or Sweet syndrome, is an inflammatory disease that classically presents with fever, leukocytosis and tender, erythematous plaques characterized by neutrophilic infiltrates on biopsy. Sweet syndrome has been reported in association with several autoimmune diseases, including inflammatory bowel disease, systemic lupus erythematous, rheumatoid arthritis and sarcoidosis.1 Here, we discuss a case of…

    Case Report: A Patient Presents with Rare, Fulminant SAPHO Syndrome

    October 18, 2018

    Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome is a heterogeneous, inflammatory, musculoskeletal disease. The disease is an insidious, sterile osteitis with associated skin and synovial inflammation.1 Diagnosis can prove challenging, but a thorough clinical history, high clinical suspicion and imaging techniques can help clinch it. The below case reveals a rare, fulminant presentation of…

    What Rheumatologists Should Look for in Diagnosing SAPHO Syndrome

    November 1, 2012

    SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is an obscure condition that can vex patients and clinicians

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences